{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.3.1493","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.526.3.1493/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1493","version":"eCQM Update 2020-05-07","name":"BetaBlockerTherapyIngredient","title":"Beta Blocker Therapy Ingredient","status":"active","date":"2017-05-04","description":"(Clinical Focus: This value set contains concepts that represent beta blocker therapy ingredients.),(Data Element Scope: This value set may use Quality Data Model (QDM) category related to Allergy/Intolerance.),(Inclusion Criteria: Includes only relevant concepts associated with prescribable ingredient only.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"10600","display":"Timolol"},{"code":"1202","display":"Atenolol"},{"code":"149","display":"Acebutolol"},{"code":"1520","display":"Betaxolol"},{"code":"19484","display":"Bisoprolol"},{"code":"20352","display":"carvedilol"},{"code":"2116","display":"Carteolol"},{"code":"6185","display":"Labetalol"},{"code":"6918","display":"Metoprolol"},{"code":"7226","display":"Nadolol"},{"code":"8332","display":"Pindolol"},{"code":"8787","display":"Propranolol"}]}]}}